COMMUNIQUÉS West-GlobeNewswire

-
Ipsen and Skyhawk Therapeutics announce RNA targeting research collaboration in rare neurological diseases
22/04/2024 -
Ipsen et Skyhawk Therapeutics annoncent la signature d'un accord de collaboration de recherche visant le ciblage d’ARN dans les maladies neurologiques rares
22/04/2024 -
Sandoz confirms European Commission approval of Pyzchiva® (ustekinumab), further strengthening immunology offering
22/04/2024 -
Ibogaine By David Dardashti' Investigates Correlation between Alcohol Addiction and Chemical Depression
22/04/2024 -
Ibogaine By David Dardashti Offers New Treatment Procedure In Dedication Of Autism Awareness Month
22/04/2024 -
Ibogaine By David Dardashti Initiates Collaboration with Top Psychedelic Researchers
21/04/2024 -
Quantum Electrodynamics and Ibogaine: Enhancing Work Performance
21/04/2024 -
Ibogaine By David Dardashti Encourages Patients to Practice Compassion
21/04/2024 -
Ibogaine By David Dardashti Offers Expanded Treatment Options
21/04/2024 -
Ibogaine By David Dardashti Takes Pride in Participating in Sexual Awareness Month
21/04/2024 -
Ibogaine By David Dardashti Announces New Algorithm For Alcohol Addiction
21/04/2024 -
Ibogaine by David Dardashti Introduces New Algorithm for Methadone Addiction
21/04/2024 -
Ibogaine By David Dardashti Introduces New Algorithm for Depression Treatment
21/04/2024 -
Remedium Healthcare Products Launches NuVeria Labs' Groundbreaking Sacral Silicone Dressing, Now Available for Purchase on Amazon Prime
20/04/2024 -
Vaxxinity Issues Shareholder Letter
20/04/2024 -
Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
19/04/2024 -
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
19/04/2024 -
ASLAN Pharmaceuticals Announces Receipt of Nasdaq Notice
19/04/2024 -
StateHouse Provides an Update on Application for Management Cease Trade Order
19/04/2024
Pages